Viewing nowRocartan Tablets 50 mg (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
KMS Pharmaceutical Co., Ltd.

MFDS item code 200502672 · Notified 2005.05.04 · Insurance code 654700150
Treatment of hypertension and diabetic nephropathy associated with hypertension
This medication helps in controlling blood pressure in patients with hypertension and is used particularly for the treatment of nephropathy that can occur in patients with type 2 diabetes. It contributes to lowering blood pressure, reducing the risk of cardiovascular complications, and protecting kidney function.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and taken orally twice daily, or the dose may be increased to up to 100 mg once daily if needed. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with other antihypertensive medicines (e.g., low-dose diuretics). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to up to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used blood glucose-lowering medicines (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No initial dose adjustment is necessary for elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretic treatment), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years and older weighing 20 kg or more but less than 50 kg who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years and older weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.
This medication can cause serious harm or death to the fetus if taken during pregnancy, especially during the second and third trimesters, so it must be discontinued immediately if pregnancy is confirmed. This medication should not be used in patients with certain allergic reactions, severely impaired liver function, during pregnancy or in women who may become pregnant, and in patients with hereditary angioedema. Elderly patients or those with impaired kidney function and patients with hyperkalemia should exercise increased caution when using this medication, and there is a risk of sudden drops in blood pressure, so particular care is needed during the initial administration. Although this medication has been generally safe in clinical trials, side effects such as dizziness, headaches, muscle pain, cough, and dyspepsia may occur. Rarely, severe side effects such as angioedema, liver dysfunction, and renal failure have also been reported. Taking this medication with other antihypertensive agents, potassium-sparing diuretics, or potassium supplements may cause dangerously high potassium levels in the blood, so co-administration should be avoided. The effectiveness of blood pressure control may be reduced or kidney function may deteriorate when taking non-steroidal anti-inflammatory drugs concurrently. Pregnant or nursing women are advised not to take this medication, and if it must be taken, they should consult a doctor and closely monitor the condition of the fetus and neonate. This medication should not be given to pediatric patients under 6 years of age or children with severely impaired kidney function, and caution should be exercised regarding the occurrence of adverse reactions in the elderly. In case of overdose, symptoms such as hypotension and bradycardia may occur, and appropriate medical treatment must be received immediately. This medication is not removed by hemodialysis. While taking this medication, patients who are planning to become pregnant or are already pregnant must consult healthcare providers, and potassium supplements or salt substitutes containing potassium should not be taken without consulting a doctor. When storing, keep out of reach of children, and do not transfer to another container for safety.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to avoid exposure to air and moisture, and it is safe to keep at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a longer period.
White oval film-coated tablets
Domestic use: 30 tablets/bottle, 300 tablets/bottle Export: 100 tablets (10 tablets/PTP*10)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
KMS Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.